参考文献/References:
[1] Roth GA,Foriuzanfar MH,Moran A,et al.Demgraphic and epidemiologic drivers of global cardiovascular mortality[J].N Engl J Med,2015,372(14):1333-1341.
[2] Tobin MK,Bonds JA,Minshall RD,et al.Neurogenesis and inflammation after ischemic stroke:what is known and where we go from here[J].Journal of Cerebral Blood Flow and Metabolism,2014,34(10):1573-1584.
[3] Shichita T.Molecular and cellular mechanisms underlying the sterile inflammation after ischemic stroke[J].Nihon Yakurigaku Zasshi,2018,1(151):9-14.
[4] Akgul O,Baycan OF,Bulut U,et al.Long-term prognostic value of elevated pentraxin 3 in patients undergoing primary angioplasty for ST-elevation myocardial infarction[J].Coron Artery Dis,2015,26(7):592-597.
[5] Guo R,Li YM,Wen J,et al.Elevated plasma level of pentraxin-3 predicts In-Hospital and 30-Day clinical outcomes in patients with Non-ST-Segment elevation myocardial infarction who have undergone percutaneous coronary intervention[J].Cardiology,2014,129(3):178-188.
[6] Ketter P,Yu JJ,Cap AP,et al.Pentraxin 3:an immune modulator of infection and useful marker for disease severity assessment in sepsis[J].Expert Rev Clin Immunol,2016,12(5):501-507.
[7] Ross R.Atherosclerosis--an inflammatory disease[J].N Engl J Med,1999,340(2):115-126.
[8] Violi F,Pastori D.Pentraxin3-A Link between obesity,inflammation and vascular disease?[J].Circ J,2016,80(2):327-328.
[9] Tomandlova M,Jarkovsky J,Tomandl J,et al.Prognostic value of pentraxin-3 level in patients with STEMI and its relationship with heart failure and markers of oxidative stress[J].Dis Markers,2015,2015(2):1-11.
[10] Tazaki R,Tanigawa J,Fujisaka T,et al.Plasma pentraxin3 level is associated with plaque vulnerability assessed by optical coherence tomography in patients with coronary artery disease[J].Int Heart J,2016,57(1):18-24.
[11] Nerkiz P,Doganer YC,Aydogan U,et al.Serum pentraxin-3 level in patients who underwent coronary angiography and relationship with coronary atherosclerosis[J].Medical Principles and Practice,2015,24(4):369-375.
[12] Casula M1,Montecucco F2,Bonaventura A,et al.Update on the role of Pentraxin 3 in atherosclerosis and cardiovascular diseases[J].Vascul Pharmacol,2017,12(99):1-12.
[13] Ryu WS,Kim CK,Kim BJ,et al.Pentraxin 3:a novel and Independent prognostic marker in iskemic stroke[J].Atherosclerosis,2011,220(2):581-586.
[14] Wang WM,Liu Z,Liu AJ,et al.The Zinc ion chelating agent TPEN attenuates neuronal death/apoptosis caused by hypoxia/ischemia via mediating the pathophysiological cascade including excitotoxicity,oxidative stress,and inflammation[J].CNS Neurosci Ther,2015,21(9):708-717.
[15] Fornai F,Carrizzo A,Forte M,et al.The inflammatory protein Pentraxin 3 in cardiovascular disease[J].Immunity & Ageing,2016,13(1):25.
[16] 李巧思,毕国荣.正五聚蛋白3与脑缺血[J].国际脑血管病杂志,2016,24(5):469-472.
[17] Iadecola C,Anrather J.The immunology of stroke:from mechanisms to translation[J].Nat Med,2011,17(7):796-808.
[18] Chawla A.Control of macrophage activation and function by PPARs[J].Circ Res,2010,106(10):1559-1569.
[19] lee Y,lee SR,Choi SS,et al.Therapeutically targeting neuroinflammation and microglia after acute ischemic stroke[J].BioMed Research International,2014,2014(1):297241.
[20] Ohab JJ,Carmichael ST.Poststroke neurogenesis:emerging principles of migration and localization of immature neurons[J].Neuroscientist,2008,14(4):369-380.
[21] Rodriguez-Grande B,Swana M,Nguyen LA,et al.The acute-phase protein PTX3 is an essential mediator of glial scar formation and resolution of brain edema after ischemic injury[J].Journal of Cerebral Blood Flow and Metabolism,2014,34(3):480-488.
[22] Leali D,Inforzato A,Ronca R,et al.Long pentraxin 3/tumor necrosis factor-stimulated gene-6 interaction[J].Arterioscler Thromb Vasc Biol,2012,32(3):696-703.
[23] Rodriguez-Grande B,Varghese L,Molina-Holgado F,et al.Pentraxin 3 mediates neurogenesis and angio-genesis after cerebral ischaemia[J].J Neuroinflammation,2015,12(6):15.
[24] Keaney J,Campbell M.The dynamic blood-brain barrier[J].FEBS J,2015,282(21):4067-4079.
[25] Argaw AT,Asp L,Zhang J,et al.Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS infiammatory disease[J].J Clin Invest,2012,122(7):2454-2468.
[26] Chen YJ,Zhang Y,Tang JJ,et al.Norrin protected Blood-Brain barrier via frizzled-4/beta-Catenin pathway after subarachnoid hemorrhage in rats[J].Stroke,2015,46(2):529-536.
[27] Argaw AT,Gurfein BT,Zhang Y,et al.VEGF-mediateddisruption of endothelial CLN-5 promotes blood-brain barrier breakdown[J].Proc Natl Acad Sci U S A,2009,106(6):1977-1982.